{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:11:21Z","timestamp":1772003481921,"version":"3.50.1"},"reference-count":38,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_rir-2022-0034_s_005\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Topical administration of Tacrolimus (TAC) is efective in the treatment of psoriasis in human patients and in mouse models. Previously, we showed that, though promoting the proliferative expansion of CD4<jats:sup>+<\/jats:sup>Foxp3<jats:sup>+<\/jats:sup> regulatory T cells (Tregs), TNFR2 was protective in mouse psoriasis model. We thus examined the role of TNFR2 signal in the efect of TAC in the treatment of mouse psoriasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2022-0034_s_006\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To this end, psoriasis was induced in WT, or TNFR1 KO, or TNFR2 KO mice, and the psoriatic mice were treated with or without IMQ.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2022-0034_s_007\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The results showed that TAC treatment potently inhibited the development of psoriasis in WT and TNFR1 KO mice, but not in TNFR2 KO mice. However, the treatment of TAC failed to induce the expansion of Tregs in psoriatic mice. In addition to playing a decisive role in the activation of Tregs, TNFR2 stimulates the generation and activation of myeloid-derived suppressor cells (MDSCs). This led us to found that the topical treatment with TAC markedly increased the number of MDSCs in the spleen of WT and TNFR1 KO mice, but not in TNFR2 KO mice. Consequently, TAC potently decreased serum levels of IL-17A, INF-\u03b3, and TNF and their mRNA levels in the inflamed skin lesion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_rir-2022-0034_s_008\">\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Therefore, our study for the first time found that the therapeutic efect of TAC in psoriasis is associated with the expansion of MDSCs in a TNFR2-dependent manner.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2478\/rir-2022-0034","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T10:51:25Z","timestamp":1675767085000},"page":"190-197","source":"Crossref","is-referenced-by-count":6,"title":["The therapeutic effect of tacrolimus in a mouse psoriatic model is associated with the induction of myeloid-derived suppressor cells"],"prefix":"10.2478","volume":"3","author":[{"given":"Shaokui","family":"Chen","sequence":"first","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Liao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Xi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Shenzhen Second People\u2019s Hospital , Shenzhen 518035 , Guangdong Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Sahidul","family":"Islam","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zibei","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"},{"name":"Department of Clinical Pharmacy, Guangzhou Hospital of Integrated Traditional and Western Medicine , Guangzhou 510000, Guangdong Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau , Macau SAR 999078 , China"},{"name":"Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau , Macau SAR 999078 , China"},{"name":"MoE Frontiers Science Center for Precision Oncology, University of Macau , Macau SAR 999078 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,12,31]]},"reference":[{"key":"2023022810512934674_j_rir-2022-0034_ref_001","unstructured":"Boehncke WH, and Sch\u00f6n MP. Psoriasis. Lancet. 2015;386: 983\u2013994."},{"key":"2023022810512934674_j_rir-2022-0034_ref_002","unstructured":"Schlaak JF, Buslau M, Jochum W, et al. T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset. J Invest Dermatol. 1994;102:145\u2013149."},{"key":"2023022810512934674_j_rir-2022-0034_ref_003","unstructured":"Austin LM, Ozawa M, Kikuchi T, et al. The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-Gamma, Interleukin-2, and Tumor Necrosis Factor-Alpha, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations: A Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients. J Invest Dermatol. 1999;113:752\u2013759."},{"key":"2023022810512934674_j_rir-2022-0034_ref_004","unstructured":"Lew W, Bowcock AM, Krueger JG. Psoriasis Vulgaris: Cutaneous Lymphoid Tissue Supports T-Cell Activation and \u201cType 1\u201d Inflammatory Gene Expression. Trends Immunol. 2004;25:295\u2013305."},{"key":"2023022810512934674_j_rir-2022-0034_ref_005","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol. 2014;32:227\u2013255."},{"key":"2023022810512934674_j_rir-2022-0034_ref_006","unstructured":"Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 Cytokines Interleukin (IL)-17 and IL-22 Modulate Distinct Inflammatory and Keratinocyte-Response Pathways. Br J Dermatol. 2008;159:1092\u20131102."},{"key":"2023022810512934674_j_rir-2022-0034_ref_007","unstructured":"Chen X, B\u00e4umel M, M\u00e4nnel DN, et al. Interaction of TNF with TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells. J Immunol. 2007;179:154\u2013161."},{"key":"2023022810512934674_j_rir-2022-0034_ref_008","unstructured":"Chen X, Wu X, Zhou Q, et al. TNFR2 is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T. Cell Phenotype in the Inflammatory Environment. J Immunol. 2013;190:1076\u20131084."},{"key":"2023022810512934674_j_rir-2022-0034_ref_009","unstructured":"Yang S, Xie C, Chen Y, et al. Differential Roles of TNF\u03b1-TNFR1 and TNF\u03b1-TNFR2 in the Differentiation and Function of CD4+Foxp3+ Induced Treg Cells in Vitro and in Vivo Periphery in Autoimmune Diseases. Cell Death Dis. 2019;10:27."},{"key":"2023022810512934674_j_rir-2022-0034_ref_010","unstructured":"Chen S, Lin Z, Xi L, et al. Differential Role of TNFR1 and TNFR2 in the Development of Imiquimod-Induced Mouse Psoriasis. J Leukoc Biol. 2021;110:1047\u20131055."},{"key":"2023022810512934674_j_rir-2022-0034_ref_011","unstructured":"Lemster BH, Carroll PB, Rilo HR, et al. IL-8\/IL-8 Receptor Expression in Psoriasis and the Response to Systemic Tacrolimus (FK506) Therapy. Clin Exp Immunol. 1995;99: 148\u2013154."},{"key":"2023022810512934674_j_rir-2022-0034_ref_012","unstructured":"Noguchi A, Tominaga M, Takahashi N, et al. Differences in Therapeutic Effects of Topically Applied Corticosteroid and Tacrolimus on Atopic Dermatitis-Like Symptoms in NC\/Nga Mice. J Dermatol Sci. 2017;86:54\u201362."},{"key":"2023022810512934674_j_rir-2022-0034_ref_013","unstructured":"Gabriel D, Mugnier T, Courthion H, et al. Improved Topical Delivery of Tacrolimus: A Novel Composite Hydrogel Formulation for the Treatment of Psoriasis. J Control Release. 2016;242:16\u201324."},{"key":"2023022810512934674_j_rir-2022-0034_ref_014","unstructured":"Lee SK, Park MJ, Jhun JY, et al. Combination Treatment with Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance. Front Immunol. 2021;11:581728."},{"key":"2023022810512934674_j_rir-2022-0034_ref_015","unstructured":"He T, Yang D, Li XQ, et al. Inhibition of Two-Pore Channels in Antigen-Presenting Cells Promotes the Expansion of TNFR2-Expressing CD4+Foxp3+ Regulatory T Cells. Sci Adv. 2020;6:eaba6584."},{"key":"2023022810512934674_j_rir-2022-0034_ref_016","unstructured":"Chen S, Lin Z, He T, et al. Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4+Foxp3+ Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice. Front Immunol. 2022;13:800283."},{"key":"2023022810512934674_j_rir-2022-0034_ref_017","unstructured":"van der Fits L, Mourits S, Voerman JS, et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice is Mediated via the IL-23\/IL-17 Axis. J Immunol. 2009;182:5836\u20135845."},{"key":"2023022810512934674_j_rir-2022-0034_ref_018","unstructured":"Mao KL, Fan ZL, Yuan JD, et al. Skin-Penetrating Polymeric Nanoparticles Incorporated in Silk Fibroin Hydrogel for Topical Delivery of Curcumin to Improve its Therapeutic Effect on Psoriasis Mouse Model. Colloids Surf B Biointerfaces. 2017;160:704\u2013714."},{"key":"2023022810512934674_j_rir-2022-0034_ref_019","unstructured":"Na Takuathung M, Wongnoppavich A, Panthong A, et al. Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB\/c Mice. Evid Based Complement Alternat Med. 2018;2018:7931031."},{"key":"2023022810512934674_j_rir-2022-0034_ref_020","unstructured":"Chen S, Lin Z, Xi L, et al. Differential Role of TNFR1 and TNFR2 in the Development of Imiquimod-Induced Mouse Psoriasis. J Leukoc Biol. 2021;110:1047\u20131055."},{"key":"2023022810512934674_j_rir-2022-0034_ref_021","unstructured":"Hu X, Li B, Li X, et al. Transmembrane TNF-\u03b1 Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2. J Immunol. 2014;192:1320\u20131331."},{"key":"2023022810512934674_j_rir-2022-0034_ref_022","unstructured":"Zhao X, Rong L, Zhao X, et al. TNF Signaling Drives Myeloid-Derived Suppressor Cell Accumulation. J Clin Invest. 2012;122:4094\u20134104."},{"key":"2023022810512934674_j_rir-2022-0034_ref_023","unstructured":"Grine L, Dejager L, Libert C, et al. Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice. J Immunol. 2015;194:5094\u20135102."},{"key":"2023022810512934674_j_rir-2022-0034_ref_024","unstructured":"Kim CH, Yoo JK, Jeon SH, et al. Anti-Psoriatic Effect of Myeloid-Derived Suppressor Cells on Imiquimod-Induced Skin Inflammation in Mice. Scand J Immunol. 2019;89:e12742."},{"key":"2023022810512934674_j_rir-2022-0034_ref_025","unstructured":"Wang W, Jiao Z, Duan T, et al. Functional Characterization of Myeloid-Derived Suppressor Cell Subpopulations during the Development of Experimental Arthritis. Eur J Immunol. 2015;45:464\u2013473."},{"key":"2023022810512934674_j_rir-2022-0034_ref_026","unstructured":"Park MJ, Lee SH, Kim EK, et al. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2016;68:2717\u20132727."},{"key":"2023022810512934674_j_rir-2022-0034_ref_027","unstructured":"Zhao X, Rong L, Zhao X, et al. TNF Signaling Drives Myeloid-Derived Suppressor Cell Accumulation. J Clin Invest. 2012;122:4094\u20134104."},{"key":"2023022810512934674_j_rir-2022-0034_ref_028","unstructured":"Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: A New Immunosuppressive Agent. Am J Health Syst Pharm. 1995;52:1521\u20131535."},{"key":"2023022810512934674_j_rir-2022-0034_ref_029","unstructured":"Frantz T, Wright EG, Balogh EA, et al. Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis. Children (Basel). 2019;6:125."},{"key":"2023022810512934674_j_rir-2022-0034_ref_030","unstructured":"Yang F, Li Y, Zhang Q, et al. The Effect of Immunosuppressive Drugs on MDSCs in Transplantation. J Immunol Res. 2018;2018:5414808."},{"key":"2023022810512934674_j_rir-2022-0034_ref_031","unstructured":"Herbst S, Shah A, Mazon Moya M, et al. Phagocytosis-Dependent Activation of a TLR9-BTK-Calcineurin-NFAT Pathway Co-Ordinates Innate Immunity to Aspergillus Fumigatus. EMBO Mol Med. 2015;7:240\u2013258."},{"key":"2023022810512934674_j_rir-2022-0034_ref_032","unstructured":"Kim YS, Kim YJ, Lee JM, et al. Functional Changes in Myeloid-Derived Suppressor Cells (MDSCs) During Tumor Growth: FKBP51 Contributes to the Regulation of the Immunosuppressive Function of MDSCs. J Immunol. 2012;188: 4226\u20134234."},{"key":"2023022810512934674_j_rir-2022-0034_ref_033","unstructured":"Rosborough BR, Ra\u00efch-Regu\u00e9 D, Turnquist HR, et al. Regulatory Myeloid Cells in Transplantation. Transplantation. 2014;97:367\u2013379."},{"key":"2023022810512934674_j_rir-2022-0034_ref_034","unstructured":"Iglesias-Escudero M, Sansegundo-Arribas D, Riquelme P, et al. Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy. Front Immunol. 2020;11:643."},{"key":"2023022810512934674_j_rir-2022-0034_ref_035","unstructured":"Regmi S, Pathak S, Nepal MR, et al. Inflammation-Triggered Local Drug Release Ameliorates Colitis by Inhibiting Dendritic Cell Migration and Th1\/Th17 Differentiation. J Control Release. 2019;316:138\u2013149."},{"key":"2023022810512934674_j_rir-2022-0034_ref_036","unstructured":"Wang Z, Shi B, Jin H, et al. Low-Dose of Tacrolimus Favors the Induction of Functional CD4(+)CD25(+)FoxP3(+) Regulatory T Cells in Solid-Organ Transplantation. Int Immunopharmacol. 2009;9:564\u2013569."},{"key":"2023022810512934674_j_rir-2022-0034_ref_037","unstructured":"Akimova T, Kamath BM, Goebel JW, et al. Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients. Am J Transplant. 2012;12:3449\u20133461."},{"key":"2023022810512934674_j_rir-2022-0034_ref_038","unstructured":"Shen Z, Song Q, Chen L, et al. Bidirectional Immunoregulation of Calcineurin Inhibitor Tacrolimus on FOXP3 Transcription? Med Hypotheses. 2011;76:178\u2013180."}],"container-title":["Rheumatology and Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/rir-2022-0034\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/rir-2022-0034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T05:52:39Z","timestamp":1677563559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.2478\/rir-2022-0034\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,31]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.2478\/rir-2022-0034"],"URL":"https:\/\/doi.org\/10.2478\/rir-2022-0034","relation":{},"ISSN":["2719-4523"],"issn-type":[{"value":"2719-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}